“Here the safety follow-up is longer. So, what we have done is that we have presented interim data. The trial design is such that one month...

Bharat Biotech has completed the Phase 2/3 trials of COVID-19 vaccine Covaxin for use in children under 18 years of age.

Children over the age of 12 with underlying medical conditions are likely to be vaccinated first, while healthy kids are unlikely to get ja...

Experts said it would be best to explain the risks and benefits to pregnant women and allow them to make an informed choice, while recordin...

"The screening of children for conducting trial of Covaxin has started. Participants would be given the vaccine after their screening repor...

“It will be a trial on children aged 2-18 years,” said Raches Ella, Bharat Bio’s head-business development and international advocacy, addr...

Different ministries will be involved in the vaccination drive starting this week. The exercise is going to be one of the largest immunizat...

While most experts are confident that India will get a vaccine, their concern is how the country will scale up to vaccinate its 1.3 billion...

The big ‘but’ butts into scalability. The usual sticking point of lab-to-arm is hugely multiplied when dealing with a totally new vaccine a...